In the news

October 6, 2020 | Purdue Newsroom

DARPA selects Continuity Pharma, funds continuous manufacturing technology

The COVID-19 pandemic has created supply chain gaps in critical drug products, especially those needed for the most critical patients in intensive care units across the country.

July 8, 2020 | Purdue Newsroom

LyoHUB adds new course in freeze-drying to resources that can assist COVID-19 research in diagnostics, therapeutics and vaccines

LyoHUB, a university-industry center at Purdue whose goal is the efficiency, science and technology of freeze-drying in pharmaceuticals and other areas, is offering a new free online course and other resources to help others’ research — including efforts related to COVID-19 — benefit from LyoHUB’s facilities and knowledge.

September 5, 2019 | Purdue Newsroom

NIBRT announces appointment of Purdue’s Elizabeth Topp as chief scientific officer

Ireland’s National Institute for Bioprocessing Research and Training (NIBRT) announced Monday (Sept. 2) the appointment of Elizabeth Topp, a professor in the College of Pharmacy at Purdue University, as chief scientific officer.

June 18, 2019 | Purdue Newsroom

NSF grant could help enable ‘self-driving’ pharmaceutical lyophilizers

A group of Purdue researchers, led by AAE Professor Alina Alexeenko, were selected for a National Science Foundation grant to develop real-time sensor technologies, computational modeling and bioanalytical tools for closed-loop lyophilization.

May 7, 2019 | Purdue Newsroom

Purdue CP3 and Applied Materials, Inc. bring SmartFactory RxTM to advanced pharmaceutical manufacturing systems

Purdue Center for Particulate Products and Processes (CP3) commissioned the Applied SmartFactory Rx software solutions provided by Applied Materials, Inc., to extend operational excellence in continuous manufacturing and advanced pharmaceutical manufacturing systems.

March 7, 2019 | Purdue Newsroom

Researchers at Purdue Center for Cancer Research develop innovative, more cost-effective method to make drugs

The Food and Drug Administration wants the pharmaceutical industry to get away from making drugs using the traditional batch method and switch to a more modern process known as continuous manufacturing.